Inlight Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$45.7K 51
2025
Q4
$45.7K Hold
200
0.02% 104
2025
Q3
$46.3K Hold
200
0.02% 99
2025
Q2
$37.1K Hold
200
0.02% 107
2025
Q1
$41.9K Buy
+200
New +$38.9K 0.03% 104

Other funds holding ABBV

Inlight Wealth Management's ABBV Position: Q1 2026 in Review

Inlight Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 200 shares — an estimated $45.7K sold.

Inlight Wealth Management first reported a position in ABBV in Q1 2025 and held it in 4 quarters. The position peaked at $46.3K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Inlight Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Inlight Wealth Management sold 200 AbbVie shares in Q1 2026, an estimated $45.7K.
  • Inlight Wealth Management first reported a position in AbbVie in Q1 2025 and held it in 4 quarters.
  • Inlight Wealth Management's AbbVie position peaked at $46.3K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Inlight Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.